Get Live Data

SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. STATEMENT RE IMMUNOCORE HOLDINGS PLC

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

STATEMENT RE IMMUNOCORE HOLDINGS PLC

12 Nov 2024 07:00

RNS Number : 7938L
BioPharma Credit PLC
12 November 2024
 

BioPharma Credit PLC

12 November 2024

 

 

 

 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

STATEMENT RE Immunocore Holdings plc

 

Pharmakon Advisors, LP, the investment manager of the Company, notes the announcement released 8 November 2024 by Immunocore Holdings plc ("Immunocore") regarding the prepayment in full of the US$50 million senior secured term loan, of which the Company had an investment of US$25 million. The prepayment included a US$1.5 million prepayment fee, of which the Company received US$750,000. 

 

The Company had previously announced on 21 November 2022 an investment in a senior secured loan to Immunocore of up to US$100 million in up to two tranches. The Company had previously funded US$25 million and Immunocore did not draw the second tranche. In connection with this final repayment, the Company received US$1,014,063 of accrued interest and prepayment fees.

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 509

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDGBDBUSBDGSB
12345678910
Date   Source Headline
9th Jun 20268:00 amRNSNEW INVESTMENT
3rd Jun 202611:40 amRNSNew Investment
1st Jun 20264:51 pmRNSDirector/PDMR Shareholding
1st Jun 20261:39 pmRNSTotal Voting Rights
26th May 20266:15 pmRNSTransaction in Own Shares
22nd May 20266:15 pmRNSTransaction in Own Shares
22nd May 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st May 20266:15 pmRNSTransaction in Own Shares
20th May 20266:15 pmRNSTransaction in Own Shares
15th May 20266:15 pmRNSTransaction in Own Shares
6th May 20265:47 pmRNSTransaction in Own Shares
6th May 20267:00 amRNSSTATEMENT RE ALPHATEC PREPAYMENT
6th May 20267:00 amRNSNotice of AGM
5th May 20267:00 amRNSStatement re ARCHIMED
1st May 202612:09 pmRNSTotal Voting Rights
29th Apr 20266:15 pmRNSTransaction in Own Shares
29th Apr 20265:03 pmRNSHolding(s) in Company
27th Apr 20266:15 pmRNSTransaction in Own Shares
24th Apr 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Apr 20264:10 pmRNSDividend Declaration
16th Apr 20265:59 pmRNSDirector/PDMR Shareholding
14th Apr 20265:44 pmRNSTransaction in Own Shares
13th Apr 20265:07 pmRNSTransaction in Own Shares
10th Apr 20265:36 pmRNSTransaction in Own Shares
10th Apr 20267:00 amRNSInvestor Presentation via Investor Meet Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20266:15 pmRNSTransaction in Own Shares
25th Mar 20266:23 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSAnnual Financial Report
20th Mar 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Mar 202611:26 amRNSUPDATE ON INVESTMENT PORTFOLIO
17th Mar 20267:00 amRNSNEW INVESTMENT OF US$125 MILLION
17th Mar 20267:00 amRNSNEW INVESTMENT OF US$125 MILLION
2nd Mar 20261:39 pmRNSUPDATE ON INVESTMENT
20th Feb 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Feb 20265:20 pmRNSDividend Declaration
3rd Feb 20267:00 amRNSNotice of Full Year Results
23rd Jan 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
30th Dec 20251:32 pmRNSSTATEMENT RE COLLEGIUM PREPAYMENT
30th Dec 20251:32 pmRNSSTATEMENT RE COLLEGIUM PREPAYMENT
19th Dec 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Nov 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
4th Nov 20253:29 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Oct 20257:00 amRNSUPDATES ON INVESTMENT PORTFOLIO
7th Oct 20257:00 amRNSNEW INVESTMENT OF US$30 MILLION
23rd Sep 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Sep 20257:00 amRNSHalf-year Report
18th Sep 20255:15 pmRNSDividend Declaration
3rd Sep 202512:21 pmRNSNEW INVESTMENT OF UP TO US$62.5 MILLION
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CLDN
Caledonia
LSE
1.57%
ZQ30
Citi Fun 33
LSE
0.00%
EBQ
Ebiquity
LSE
0.00%
BIPS
Invesco Bd In
LSE
0.00%
IBST
Ibstock
LSE
3.43%
Trending
ALRT
Defence Holdings
LSE
4.51%
IMM
Immupharma
LSE
5.42%
HPOW
H-power
LSE
-1.57%
NANO
Nanoco
LSE
18.64%
PPP
Pennpetro Energy
LSE
0.00%